Next-generation Life Sciences Facilities

It is imperative for drug manufacturers to accelerate the adoption of innovative technologies to address the situation and bring transformational changes to the way the lifecycle of medicinal products are managed. Facilities play a critical role in creating an environment where medicines are manufactured to a consistent quality with minimal cost. The performance of facilities is a critical factor in maintaining business continuity and production uptime. According to the FDA, failures in product or facility quality are the leading cause of disruption to manufacturing – resulting in 66% of all drug shortages. To better understand the risks to production and the environment, facility management requires a pro-active approach when developing processes to capture and analyze data. Let’s examine the five key risk factors for Life Sciences facilities and transform them into opportunities for business.